Clinical Trial Update: Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase

View source ↗

Summary

This clinical trial update notes recruitment for ponatinib in patients with chronic myeloid leukemia in chronic phase at the University of Pisa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Ponatinib (ponatinib)

Snippet

Sponsor: University of Pisa | Conditions: Chronic Myeloid Leukemia, Chronic Phase | Status: RECRUITING